Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans

Molecular Nutrition and Food Research

Volumn 59, Issue 9, 2015, Pages 1651-1662

  Actis Goretta, Lucas ^a   Dew, Tristan P ^b   Lévèques, Antoine ^a   Pereira Caro, Gema ^c   Rein, Maarit ^a   Teml, Alexander ^d   Schäfer, Christian ^e   Hofmann, Ute ^d   Schwab, Matthias ^f   Eichelbaum, Michel ^d   Crozier, Alan ^g   Williamson, Gary ^h  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c IFAPA CENTRO ALAMEDA DEL OBISPO   (Spain)

^d DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^e ROBERT BOSCH HOSPITAL   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Absorption; Hesperetin glycosides; Humans; Metabolism; Oral intake; Perfusion of proximal jejunum

Indexed keywords

HESPERETIN-7-GLUCOSIDE; HESPERIDIN;

ADULT; ANALOGS AND DERIVATIVES; BIOAVAILABILITY; BLOOD; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECTS; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; URINE; YOUNG ADULT;

ADULT; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; BODY MASS INDEX; CROSS-OVER STUDIES; FEMALE; GASTROINTESTINAL ABSORPTION; HEALTHY VOLUNTEERS; HESPERIDIN; HUMANS; MALE; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84942838907     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500202     Document Type: Article

References (28)

1. Hertog, M. G., Epidemiological evidence on potential health properties of flavonoids. Proc. Nutr. Soc. 1996, 55, 385-397.
2. Mink, P. J., Scrafford, C. G., Barraj, L. M., Harnack, L. et al., Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85, 895-909.
3. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B. et al., Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342, 1007-1011.
4. Arts, I. C., Hollman, P. C., Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S-325S.
5. Borges, G., Mullen, W., Mullan, A., Lean, M. E. et al., Bioavailability of multiple components following acute ingestion of a polyphenol-rich juice drink. Mol. Nutr. Food Res. 2010, 54, 268-274.
6. Manach, C., Williamson, G., Morand, C., Scalbert, A. et al., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
7. Hollman, P. C., Bijsman, M. N., vanGameren, Y., Cnossen, E. P. et al., The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res. 1999, 31, 569-573.
8. Vallejo, F., Larrosa, M., Escudero, E., Zafrilla, M. P. et al., Concentration and solubility of flavanones in orange beverages affect their bioavailability in humans. J. Agric. Food Chem. 2010, 58, 6516-6524.
9. Manach, C., Morand, C., Gil-Izquierdo, A., Bouteloup-Demange, C. et al., Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. 2003, 57, 235-242.
10. Morand, C., Dubray, C., Milenkovic, D., Lioger, D. et al., Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am. J. Clin. Nutr. 2011, 93, 73-80.
11. Milenkovic, D., Deval, C., Dubray, C., Mazur, A. et al., Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One 2011, 6, e26669.
12. Nielsen, I. L., Chee, W. S., Poulsen, L., Offord-Cavin, E. et al., Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J. Nutr. 2006, 136, 404-408.
13. Bredsdorff, L., Nielsen, I. L., Rasmussen, S. E., Cornett, C. et al., Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects. Br. J. Nutr. 2010, 103, 1602-1609.
14. Borges, G., Lean, M. E., Roberts, S. A., Crozier, A., Bioavailability of dietary (poly)phenols: a study with ileostomists to discriminate between absorption in small and large intestine. Food Funct. 2013, 4, 754-762.
15. Manach, C., Morand, C., Texier, O., Favier, M. L. et al., Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 1995, 125, 1911-1922.
16. Manach, C., Morand, C., Demigne, C., Texier, O. et al., Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997, 409, 12-16.
17. Actis-Goretta, L., Leveques, A., Rein, M., Teml, A. et al., Intestinal absorption, metabolism, and excretion of (-)-epicatechin in healthy humans assessed by using an intestinal perfusion technique. Am. J. Clin. Nutr. 2013, 98, 924-933.
18. von Richter, O., Greiner, B., Fromm, M. F., Fraser, R. et al., Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique. Clin. Pharmacol. Ther. 2001, 70, 217-227.
19. Glaeser, H., Drescher, S., Hofmann, U., Heinkele, G. et al., Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humans. Clin. Pharmacol. Ther. 2004, 76, 230-238.
20. Drescher, S., Glaeser, H., Murdter, T., Hitzl, M. et al., P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin. Pharmacol. Ther. 2003, 73, 223-231.
21. Leveques, A., Actis-Goretta, L., Rein, M. J., Williamson, G. et al., UPLC-MS/MS quantification of total hesperetin and hesperetin enantiomers in biological matrices. J. Pharm. Biomed. Anal. 2012, 57, 1-6.
22. Pereira-Caro, G., Borges, G., vander Hooft, J., Clifford, M. N. et al., Orange juice (poly)phenols are highly bioavailable in humans. Am. J. Clin. Nutr. 2014, 100, 1378-1384.
23. Habauzit, V., Nielsen, I. L., Gil-Izquierdo, A., Trzeciakiewicz, A. et al., Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats. Br. J. Nutr. 2009, 102, 976-984.
24. Day, A. J., Canada, F. J., Diaz, J. C., Kroon, P. A. et al., Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000, 468, 166-170.
25. Krogholm, K. S., Bredsdorff, L., Knuthsen, P., Haraldsdottir, J. et al., Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet. Eur. J. Clin. Nutr. 2010, 64, 432-435.
26. Kanaze, F. I., Bounartzi, M. I., Georgarakis, M., Niopas, I., Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 2007, 61, 472-477.
27. Yamamoto, M., Jokura, H., Suzuki, A., Hase, T. et al., Effects of continuous ingestion of hesperidin and glucosyl hesperidin on vascular gene expression in spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 2013, 59, 470-473.
28. Chanet, A., Milenkovic, D., Claude, S., Maier, J. A. et al., Flavanone metabolites decrease monocyte adhesion to TNF-alpha-activated endothelial cells by modulating expression of atherosclerosis-related genes. Br. J. Nutr. 2013, 110, 587-598.